ESR1 and breast cancer: Currently, the most common endocrine therapy agents used in breast cancer include selective estrogen receptor modulators (SERMs), aromatase inhibitors (AIs), selective estrogen receptor degraders (SERDs), and ovarian function suppression (OFS).